Metropolis Healthcare Limited (BOM:542650)
India
· Delayed Price · Currency is INR 1,690.30
-7.35 (-0.43%)
At close: Jun 11, 2025
Metropolis Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 13,312 | 12,077 | 11,482 | 12,283 | 9,980 | Upgrade
|
| Revenue Growth (YoY) | 10.22% | 5.18% | -6.52% | 23.08% | 16.53% | Upgrade
|
| Cost of Revenue | 2,687 | 2,699 | 2,741 | 2,976 | 2,702 | Upgrade
|
| Gross Profit | 10,625 | 9,378 | 8,742 | 9,307 | 7,278 | Upgrade
|
| Selling, General & Admin | 3,137 | 4,138 | 3,730 | 3,649 | 2,746 | Upgrade
|
| Research & Development | 102 | 135.77 | 65.71 | 69.07 | 54.46 | Upgrade
|
| Other Operating Expenses | 4,356 | 2,209 | 2,017 | 2,140 | 1,594 | Upgrade
|
| Operating Expenses | 8,682 | 7,427 | 6,704 | 6,491 | 4,854 | Upgrade
|
| Operating Income | 1,943 | 1,951 | 2,037 | 2,817 | 2,423 | Upgrade
|
| Interest Expense | -185.75 | -225.36 | -268.01 | -197.42 | -77.82 | Upgrade
|
| Interest & Investment Income | - | 69.1 | 102.3 | 111.48 | 93.01 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -59.57 | -1.84 | -6.11 | -22.77 | Upgrade
|
| Other Non Operating Income (Expenses) | 151.13 | - | -0 | 48.02 | 20.1 | Upgrade
|
| EBT Excluding Unusual Items | 1,909 | 1,735 | 1,870 | 2,773 | 2,436 | Upgrade
|
| Impairment of Goodwill | - | - | - | -1.88 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 11.56 | 6.78 | 4.26 | 7.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.08 | -0.16 | -0.11 | Upgrade
|
| Asset Writedown | - | - | -1.35 | -0.34 | - | Upgrade
|
| Other Unusual Items | - | - | - | 159.02 | - | Upgrade
|
| Pretax Income | 1,909 | 1,747 | 1,875 | 2,934 | 2,443 | Upgrade
|
| Income Tax Expense | 453.39 | 462.33 | 441.09 | 786.65 | 609.74 | Upgrade
|
| Earnings From Continuing Operations | 1,455 | 1,285 | 1,434 | 2,147 | 1,833 | Upgrade
|
| Minority Interest in Earnings | -5.46 | -6.39 | -5.11 | -5.04 | -2.54 | Upgrade
|
| Net Income | 1,450 | 1,278 | 1,429 | 2,142 | 1,831 | Upgrade
|
| Net Income to Common | 1,450 | 1,278 | 1,429 | 2,142 | 1,831 | Upgrade
|
| Net Income Growth | 13.42% | -10.54% | -33.29% | 16.98% | 43.80% | Upgrade
|
| Shares Outstanding (Basic) | 51 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 51 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Change (YoY) | 0.20% | 0.05% | -0.09% | 0.49% | 1.44% | Upgrade
|
| EPS (Basic) | 28.29 | 24.95 | 27.91 | 41.87 | 35.97 | Upgrade
|
| EPS (Diluted) | 28.15 | 24.87 | 27.81 | 41.66 | 35.79 | Upgrade
|
| EPS Growth | 13.19% | -10.57% | -33.25% | 16.40% | 41.74% | Upgrade
|
| Free Cash Flow | 2,193 | 2,003 | 1,945 | 2,226 | 2,208 | Upgrade
|
| Free Cash Flow Per Share | 42.59 | 38.98 | 37.85 | 43.30 | 43.15 | Upgrade
|
| Dividend Per Share | - | 4.000 | 8.000 | 8.000 | 8.000 | Upgrade
|
| Dividend Growth | - | -50.00% | - | - | - | Upgrade
|
| Gross Margin | 79.82% | 77.65% | 76.13% | 75.77% | 72.92% | Upgrade
|
| Operating Margin | 14.60% | 16.16% | 17.74% | 22.93% | 24.28% | Upgrade
|
| Profit Margin | 10.89% | 10.58% | 12.44% | 17.44% | 18.35% | Upgrade
|
| Free Cash Flow Margin | 16.48% | 16.59% | 16.94% | 18.12% | 22.12% | Upgrade
|
| EBITDA | 3,030 | 2,176 | 2,356 | 3,067 | 2,633 | Upgrade
|
| EBITDA Margin | 22.76% | 18.02% | 20.52% | 24.97% | 26.38% | Upgrade
|
| D&A For EBITDA | 1,087 | 224.79 | 318.6 | 250.63 | 209.61 | Upgrade
|
| EBIT | 1,943 | 1,951 | 2,037 | 2,817 | 2,423 | Upgrade
|
| EBIT Margin | 14.60% | 16.16% | 17.74% | 22.93% | 24.28% | Upgrade
|
| Effective Tax Rate | 23.76% | 26.47% | 23.52% | 26.82% | 24.96% | Upgrade
|
| Revenue as Reported | 13,463 | 12,168 | 11,634 | 12,460 | 10,100 | Upgrade
|
| Advertising Expenses | - | 327.74 | 261.56 | 260.32 | 131.25 | Upgrade
|
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.